GMED Globus Medical, Inc.: Operating Margin

Corporate emblem and logo of NuVasive (GMED)

Globus Medical, Inc. (GMED) is minimizing its narrow specialization in spinal surgery by implementing its own proprietary IT navigation systems. The business's operational efficiency reflects market dynamics, where 23.00 serves as the current metric level. Growth is driven by the development of robotic systems and new implants through R&D, while portfolio diversification via high-cost robots attracts the largest orthopedic centers.

GMED: Globus Medical Operating Margin 07/04/2022 - 11/20/2026

Globus Medical, Inc. - analytical breakdowns and key metrics (GMED)

- share price and consensus valuation forecast:
Fundamental company analysis:GMED, Globus Medical Inc
Brand item of NuVasive

Professional Capital assesses the efficiency of Globus Medical, Inc. (GMED) through its ability to scale high-tech robotic spinal surgery without a proportional increase in costs. By analyzing the operating margin chart, the investor determines the share of operating profit in revenue, which confirms the monetization of ExcelsiusGPS system implementation and steady demand for ancillary implants, ensuring the fundamental stability of the asset.

Competitors of Globus Medical, Inc. (GMED)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|TMDX: Operating Profitability|ATEC (Alphatec Holdings, Inc.) - Operating Sales Margin|Artivion, Inc. - Operating Profit Rate|ENOV (Enovis Inc.) - Operating Margin|Operating Return on Sales Integra LifeSciences Corp IART|Operating Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Operating Profitability Margin|IRADIMED Inc. - Operating Sales Margin|Operating Margin Embecta Corp. EMBC|Tandem Diabetes Care Inc - Operating Margin|Profitability of Operations AxoGen Inc AXGN|SI-BONE (SIBN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)